Percutaneous closure of ventricular septal defects. State of the art

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Ventricular septal defect (VSD) is the most common congenital heart disease. Surgery has been performed for many years and is considered to be the gold standard for the treatment of VSD. However, it is associated with morbidity and mortality. Percutaneous closure of VSDs is performed under general anesthesia and with fluoroscopic and transesophageal echocardiographic guidance. Two devices of the Amplatzer family are currently used to close percutaneously muscular and perimembranous VSD with a closure rate of 97% (incidence of major complication 2.2%) and 97.5% (major acute complications in 1.2%), respectively. Occurrence of complete atrioventricular block is reported in 1% of subjects. Acquired VSD can occur as post-surgical residual leak, as a traumatic event or as consequence of a myocardial infarction. There are few data about percutaneous closure of post-surgical residual VSD and of traumatic VSD. As for the surgical approach, in patients with post-myocardial infarction VSD success rate of percutaneous closure is around 88% with a mortality of 22%. The currently available data show that, in experienced hands, percutaneous closure is a safe and effective procedure. Device closure of muscular and perimembranous VSD is a real alternative to the standard surgical approach with the advantage of a significantly reduced rate of mortality and complications.

Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalJournal of Cardiovascular Medicine
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Ventricular Heart Septal Defects
Mortality
Myocardial Infarction
Equipment and Supplies
Atrioventricular Block
General Anesthesia
Heart Diseases
Morbidity
Incidence

Keywords

  • Congenital heart defects
  • Transcatheter treatment
  • Ventricular septal defects

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{7172bb61aad0489492e4a7809b241599,
title = "Percutaneous closure of ventricular septal defects. State of the art",
abstract = "Ventricular septal defect (VSD) is the most common congenital heart disease. Surgery has been performed for many years and is considered to be the gold standard for the treatment of VSD. However, it is associated with morbidity and mortality. Percutaneous closure of VSDs is performed under general anesthesia and with fluoroscopic and transesophageal echocardiographic guidance. Two devices of the Amplatzer family are currently used to close percutaneously muscular and perimembranous VSD with a closure rate of 97{\%} (incidence of major complication 2.2{\%}) and 97.5{\%} (major acute complications in 1.2{\%}), respectively. Occurrence of complete atrioventricular block is reported in 1{\%} of subjects. Acquired VSD can occur as post-surgical residual leak, as a traumatic event or as consequence of a myocardial infarction. There are few data about percutaneous closure of post-surgical residual VSD and of traumatic VSD. As for the surgical approach, in patients with post-myocardial infarction VSD success rate of percutaneous closure is around 88{\%} with a mortality of 22{\%}. The currently available data show that, in experienced hands, percutaneous closure is a safe and effective procedure. Device closure of muscular and perimembranous VSD is a real alternative to the standard surgical approach with the advantage of a significantly reduced rate of mortality and complications.",
keywords = "Congenital heart defects, Transcatheter treatment, Ventricular septal defects",
author = "Gianfranco Butera and Massimo Chessa and Mario Carminati",
year = "2007",
month = "1",
doi = "10.2459/01.JCM.0000247434.59451.d7",
language = "English",
volume = "8",
pages = "39--45",
journal = "Journal of Cardiovascular Medicine",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Percutaneous closure of ventricular septal defects. State of the art

AU - Butera, Gianfranco

AU - Chessa, Massimo

AU - Carminati, Mario

PY - 2007/1

Y1 - 2007/1

N2 - Ventricular septal defect (VSD) is the most common congenital heart disease. Surgery has been performed for many years and is considered to be the gold standard for the treatment of VSD. However, it is associated with morbidity and mortality. Percutaneous closure of VSDs is performed under general anesthesia and with fluoroscopic and transesophageal echocardiographic guidance. Two devices of the Amplatzer family are currently used to close percutaneously muscular and perimembranous VSD with a closure rate of 97% (incidence of major complication 2.2%) and 97.5% (major acute complications in 1.2%), respectively. Occurrence of complete atrioventricular block is reported in 1% of subjects. Acquired VSD can occur as post-surgical residual leak, as a traumatic event or as consequence of a myocardial infarction. There are few data about percutaneous closure of post-surgical residual VSD and of traumatic VSD. As for the surgical approach, in patients with post-myocardial infarction VSD success rate of percutaneous closure is around 88% with a mortality of 22%. The currently available data show that, in experienced hands, percutaneous closure is a safe and effective procedure. Device closure of muscular and perimembranous VSD is a real alternative to the standard surgical approach with the advantage of a significantly reduced rate of mortality and complications.

AB - Ventricular septal defect (VSD) is the most common congenital heart disease. Surgery has been performed for many years and is considered to be the gold standard for the treatment of VSD. However, it is associated with morbidity and mortality. Percutaneous closure of VSDs is performed under general anesthesia and with fluoroscopic and transesophageal echocardiographic guidance. Two devices of the Amplatzer family are currently used to close percutaneously muscular and perimembranous VSD with a closure rate of 97% (incidence of major complication 2.2%) and 97.5% (major acute complications in 1.2%), respectively. Occurrence of complete atrioventricular block is reported in 1% of subjects. Acquired VSD can occur as post-surgical residual leak, as a traumatic event or as consequence of a myocardial infarction. There are few data about percutaneous closure of post-surgical residual VSD and of traumatic VSD. As for the surgical approach, in patients with post-myocardial infarction VSD success rate of percutaneous closure is around 88% with a mortality of 22%. The currently available data show that, in experienced hands, percutaneous closure is a safe and effective procedure. Device closure of muscular and perimembranous VSD is a real alternative to the standard surgical approach with the advantage of a significantly reduced rate of mortality and complications.

KW - Congenital heart defects

KW - Transcatheter treatment

KW - Ventricular septal defects

UR - http://www.scopus.com/inward/record.url?scp=33846569467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846569467&partnerID=8YFLogxK

U2 - 10.2459/01.JCM.0000247434.59451.d7

DO - 10.2459/01.JCM.0000247434.59451.d7

M3 - Article

C2 - 17255815

AN - SCOPUS:33846569467

VL - 8

SP - 39

EP - 45

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

SN - 1558-2027

IS - 1

ER -